Tradestie Institutional Equity Comparison Engine

BHVN vs MDGL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BHVN Overall Edge

BHVN Captures Institutional Edge (3โ€“1 Pillars ยท 3โ€“7 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Biohaven Ltd. (BHVN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while MDGL counters with relative strength in Valuation. Fundamentally, BHVN trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus MDGL at 38.1x Forward P/E and -10.7% operating margin (+50.1% YoY). In options structure, BHVN sits in CONSOLIDATION (18th %ile IV; Dealer Gamma Walls on Pro) against MDGL sits in CONSOLIDATION (13th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner MDGL
BHVN N/M vs MDGL 38.1x Fwd P/E
Growth & Margin Winner BHVN
Op Margin 0.0% vs -10.7% ยท YoY +0.0% vs +50.1%
Momentum & Technical Winner BHVN
1Y +72.1% vs -17.8% ยท 52W Pos 59% vs 27%
Options & Structure Winner BHVN
CONSOLIDATION (18th %ile IV) vs CONSOLIDATION (13th %ile IV)
BHVN NYSE
Biohaven Ltd.
Pharmaceutical Preparations
$13.90
+0.62% 1D
Market Cap $2.1B
1M Return +28.99%
1Y Return +72.09%
Forward P/E N/M
Unified AI Score
42.1 / 100 HOLD
Tech 15.0 Fund 42.0 Flow 68.0 Mom 50.0
MDGL NASDAQ
Madrigal Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$423.54
-0.9% 1D
Market Cap $9.8B
1M Return -5.83%
1Y Return -17.75%
Forward P/E 38.1x
Unified AI Score
47.6 / 100 HOLD
Tech 53.0 Fund 63.0 Flow 63.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BHVN +72.09% MDGL -17.75% Spread: +89.84 pp (BHVN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BHVN TTM Op. Margin: 0.0% MDGL TTM Op. Margin: -10.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BHVN vs MDGL. Trailing 12-month operating profitability (BHVN 0.0% vs MDGL -10.7%) and valuation multiples (BHVN N/M vs MDGL 38.1x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BHVN (3) vs MDGL (7)
Institutional Metric BHVN MDGL Criterion Row Winner
Market Capitalization Scale $2.1B $9.8B Larger Scale MDGL
Trailing P/E Ratio Valuation N/M 61.4x Lower Multiple MDGL
Forward P/E Ratio Valuation N/M 38.1x Lower Multiple MDGL
Revenue Growth (YoY) Growth +0.0% +50.1% Higher Growth MDGL
Operating Margin (TTM) Profitability 0.0% -10.7% Higher Margin BHVN
Net Profit Margin Profitability 0.0% -10.9% Higher Margin BHVN
Return on Equity (ROE) Capital Efficiency -799.5% -24.8% Higher ROE MDGL
52-Week Range Position Momentum 59% ($8โ€“$18) 27% ($354โ€“$615) Stronger Trend BHVN
Beta / 30D Volatility Risk Regime 1.41ฮฒ ยท 111% Vol 0.28ฮฒ ยท 49% Vol Lower Realized Risk MDGL
Unified Institutional Score Composite Signal 42.1 / 100 (HOLD) 47.6 / 100 (HOLD) Higher Composite MDGL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BHVN vs MDGL Buy Guide
BHVN CONSOLIDATION
91d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 18th %ile
IV Regime Compressed (<25th %ile)
Live BHVN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MDGL CONSOLIDATION
157d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 13th %ile
IV Regime Compressed (<25th %ile)
Live MDGL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BHVN nor MDGL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.